Research graph
References from Machine Learning‐Driven Noninvasive Prediction of Liver Fibrosis in Unclassified Liver Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Liver Fibrosis in NAFLD/NASH: From Pathophysiology towards Diagnostic and Therapeutic Strategies
10.1016/j.mam.2023.101231 · 2024 · External reference
Definition and Classification of Acute‐on‐Chronic Liver Diseases
10.12998/wjcc.v10.i15.4717 · 2022 · External reference
Resolution of Liver Fibrosis: Basic Mechanisms and Clinical Relevance
10.1055/s-0035-1550057 · 2015 · External reference
Non‐invasive Diagnosis and Monitoring of Non‐Alcoholic Fatty Liver Disease and Non‐alcoholic Steatohepatitis
10.1016/s2468-1253(23)00066-3 · 2023 · External reference
Guidelines on the Use of Liver Biopsy in Clinical Practice From the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology
10.1136/gutjnl-2020-321299 · 2020 · External reference
The NAFLD Fibrosis Score
10.1002/hep.21496 · 2007 · External reference
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis‐4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis
10.1016/j.cgh.2019.03.006 · 2019 · External reference
Liver Fibrosis Stage Based on the Four Factors (FIB‐4) Score or Forns Index in Adults With Chronic hepatitis C
2024 · External reference
Lean Individuals With NAFLD Have More Severe Liver Disease and Poorer Clinical Outcomes (NASH‐CO Study)
10.1097/hep.0000000000000329 · 2023 · External reference
Diagnostic Accuracy of Non‐Invasive Tests for Advanced Fibrosis in Patients With NAFLD: An Individual Patient Data Meta‐Analysis
10.1136/gutjnl-2021-324243 · 2022 · External reference
Consensus Scoring Systems for Nonalcoholic Fatty Liver Disease: An Unmet Clinical Need
10.21037/hbsn-21-80 · 2021 · External reference
New Sequential Combinations of Non‐Invasive Fibrosis Tests Provide an Accurate Diagnosis of Advanced Fibrosis in NAFLD
10.1016/j.jhep.2019.04.020 · 2019 · External reference
Artificial Intelligence in Liver Diseases: Improving Diagnostics, Prognostics and Response Prediction
10.1016/j.jhepr.2022.100443 · 2022 · External reference
Machine Learning–Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients with Hepatic Steatosis
10.1016/j.cgh.2024.06.014 · 2024 · External reference
From Local Explanations to Global Understanding With Explainable AI for Trees
10.1038/s42256-019-0138-9 · 2020 · External reference
Automated Machine Learning‐Based Model for the Prediction of Delirium in Patients After Surgery for Degenerative Spinal Disease
10.1111/cns.14002 · 2023 · External reference
Machine Learning Models Developed and Internally Validated for Predicting Chronicity in Pediatric Immune Thrombocytopenia
10.1016/j.jtha.2023.12.006 · 2024 · External reference
The Steatosis‐Associated Fibrosis Estimator (SAFE) Score: A Tool to Detect Low‐Risk NAFLD in Primary Care
10.1002/hep.32545 · 2023 · External reference
A Blood‐based Biomarker Panel for Non‐invasive Diagnosis of Metabolic Dysfunction‐associated Steatohepatitis
10.1016/j.cmet.2024.10.008 · 2025 · External reference
Exploratory Study of Extracellular Matrix Biomarkers for Non‐invasive Liver Fibrosis Staging: A Machine Learning Approach With XGBoost and Explainable AI
10.1016/j.clinbiochem.2024.110861 · 2025 · External reference
Machine Learning Algorithm Outperforms Fibrosis Markers in Predicting Significant Fibrosis in Biopsy‐Confirmed NAFLD
10.1002/jhbp.972 · 2021 · External reference
Early Screening, Diagnosis and Recurrence Monitoring of Hepatocellular Carcinoma in Patients With Chronic hepatitis B Based on Serum N‐glycomics Analysis: A Cohort Study
10.1097/hep.0000000000001316 · 2026 · External reference
Benchmarking Clinical Risk Prediction Algorithms With Ensemble Machine Learning for the Noninvasive Diagnosis of Liver Fibrosis in NAFLD
10.1097/hep.0000000000000908 · 2024 · External reference
Machine Learning Models Are Superior to Noninvasive Tests in Identifying Clinically Significant Stages of NAFLD and NAFLD‐Related Cirrhosis
10.1002/hep.32655 · 2023 · External reference
Accurate Non‐invasive Detection of MASH With Fibrosis F2‐F3 Using a Lightweight Machine Learning Model With Minimal Clinical and Metabolomic Variables
10.1016/j.metabol.2024.156082 · 2025 · External reference
Liver Diseases: Epidemiology, Causes, Trends and Predictions
10.1038/s41392-024-02072-z · 2025 · External reference
Pooling of Platelets in the Spleen: Role in the Pathogenesis of "Hypersplenic" Thrombocytopenia
10.1172/jci105380 · 1966 · External reference
Guidelines on the Management of Abnormal Liver Blood Tests
10.1136/gutjnl-2017-314924 · 2018 · External reference
Unresolved reference
External reference
Liver Disease Committee, Chinese Association of Integrative Medicine
2019 · External reference
Development of a Simple Noninvasive Index to Predict Significant Fibrosis in Patients With HIV/HCV Coinfection†‡
10.1002/hep.21178 · 2006 · External reference
Identification of Chronic hepatitis C Patients Without Hepatic Fibrosis by a Simple Predictive Model
10.1053/jhep.2002.36128 · 2002 · External reference
The Gamma‐glutamyl Transpeptidase to Platelet Ratio (GPR) Predicts Significant Liver Fibrosis and Cirrhosis in Patients With Chronic HBV Infection in West Africa
10.1136/gutjnl-2015-309260 · 2016 · External reference
Population Screening for Liver Fibrosis: Toward Early Diagnosis and Intervention for Chronic Liver Diseases
10.1002/hep.32163 · 2022 · External reference
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
10.14218/jcth.2016.00019 · 2017 · External reference
